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Fragility fractures in sub-Saharan Africa: time to break 
the myth
The number of older adults (aged ≥60 years) in Sub-
Saharan Africa is two times higher than in northern 
Europe; a igure that is expected to increase from 
46 million in 2015 to 157 million by 2050.1 In sub-
Saharan Africa, at age 60 years, life expectancy is 
16 years for women and 14 years for men, suggesting 
that for individuals who survive challenges in early 
life, a long period of old age is now a reality.1 As sub-
Saharan Africa undergoes an epidemiological transition 
as a result of rapid urbanisation, the burden of non-
communicable diseases, including osteoporosis, is 
rising. Similar to many chronic diseases such as 
hypertension, osteoporosis often remains undiagnosed 
until a fracture occurs. Increasing evidence2,3 is dispelling 
the outdated myth that fragility fractures are not a 
problem in sub-Saharan Africa.
Fragility fractures, sustained after a fall from a standing 
height or less, occur in the context of multimorbidity, 
often in combination with other syndromes associated 
with ageing, such as sarcopenia and frailty. Furthermore, 
high HIV prevalence, undernutrition and overnutrition, 
high trauma rates (eg, road traic injuries), and marked 
socioeconomic inequalities, all of which are observed 
in sub-Saharan Africa, are known to increase fragility 
fracture risk in high-income settings.4 The scale-up of 
HIV treatment has substantially improved survival, and 
consequently HIV is now considered a chronic disease 
with associated immunosenescence and premature 
ageing. Paradoxically, exposure to speciic antiretroviral 
drugs further increases fracture risk.4 Considering the 
prevalence of HIV infection in sub-Saharan Africa, the 
accelerated rollout of antiretrovirals, and the lifelong 
nature of treatment, fracture burdens are expected to 
increase across all ages and in both sexes, with more 
younger people (aged <60 years) afected in this region 
than elsewhere, directly afecting their capacity to work, 
provide for their families, and contribute to local and 
regional productivity.
Vertebral and hip fractures both substantially reduce 
quality of life, and although vertebral fractures are 
more common than hip fractures, hip fractures have 
the greatest health and economic impact.5 Even in 
high-income settings, mortality 12 months after a 
hip fracture is 30%,6 which is a poorer prognosis than 
that for most cancers. In the UK, half a million fragility 
fractures occur annually, incurring direct health costs of 
£4·3 billion7 in addition to the costs of disability, with 
the majority of survivors requiring long-term social 
support. The mean global health and social care cost 
in the irst year following a hip fracture is US$43 669 
per patient, with immediate inpatient care costing on 
average $13 331, with highly variable social care costs.8 
High-income settings have health and social systems 
that facilitate long-term care; sub-Saharan Africa does 
not. Thus, younger family members are likely to take 
responsibility for the care of older relatives, further 
afecting individuals of working age. To date, no studies 
have been published on the health costs of fractures 
within the sub-Saharan Africa region.8
The predicted increase in fractures in sub-Saharan 
Africa now means there is an urgent need to strengthen 
health-care systems. Prevention of fractures is 
preferable to, and cheaper than, treating them once 
Panel: Musculoskeletal health research priorities for sub-Saharan Africa
Epidemiology
• Incidence and prevalence of fragility fractures, including geographical and ethnic 
variation, urban and rural diferences, sex-speciic data
• Outcomes after fracture, including mortality, function and disability, quality of life
• Risk factors for fracture, especially HIV and antiretrovirals
• Understanding musculoskeletal disease within the context of multimorbidity
• Modelling estimates of future burdens of musculoskeletal disease
Health services research
• Understanding fracture care pathways
• Capacity and delivery of health services
• Patients’ views and experiences of health-care services
• Current and future costs of fracture care
• Developing innovative service delivery models, including use of diagnostic imaging
Underlying disease mechanisms
• Understanding genetic determinants of musculoskeletal phenotypes
• Factors determining quality and quantity of bone
• Skeletal biomechanics including the role of muscle
• Interactions between musculoskeletal biology and other systems
Clinical research
• Strategies for efective fracture prevention in sub-Saharan Africa
• Clinical tools to focus interventions to high-risk groups
• Efectiveness of established treatments within sub-Saharan Africa populations
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they occur. A range of relatively inexpensive generic 
osteoporosis treatments that reduce the risk of fragility 
fractures are now widely available, priced from $12 per 
year; however, none are currently included on the WHO 
Essential Medicine List. Operative treatment requires 
secondary-level care and hence long-term investment in 
orthopaedic training, which is not universally available 
in sub-Saharan Africa. Orthopaedic care should be 
delivered as part of a multidisciplinary pathway, but 
the preparedness of such teams is poorly understood, 
although indications suggest resources are grossly 
inadequate.9
Fragility fractures are life-changing events. We must 
learn from high-income countries, where osteoporosis 
treatment is often initiated too late, following multiple 
fractures and their accumulated morbidity. In settings 
with competing communicable and non-communicable 
health priorities, individuals with health outcomes that 
cause the greatest disability and health costs should 
be prioritised. In sub-Saharan Africa, an urgent need 
exists to understand the epidemiology of fractures, the 
associated inancial and societal costs, and the health-
care infrastructure required (panel). Country-speciic 
data are essential to inform health policy and resource 
allocation.
At present, a lack of awareness persists regarding 
the burden of musculoskeletal ageing in sub-Saharan 
Africa. The third Sustainable Development Goal aims to 
ensure healthy lives for all at all ages and, in 2015, WHO 
highlighted the need for action to prevent and manage 
fragility fractures in sub-Saharan Africa in the next 
decade.10 The myth that osteoporotic fragility fractures 
only occur in older white women is outdated. An urgent 
and compelling need exists to deliver research that 
can inform prevention and management of fragility 
fractures in sub-Saharan Africa.
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